PD-L1 x ABCB1

N/A

Report date: 2025/01/26 16:30:04

Base Information

Drug NamePD-L1 x ABCB1
Drug Alias Nameanti-ABCB1 efflux pump/PD-L1 checkpoint inhibitor bispecific antibody (Kenjockety Biotechnology)Anti-PD-L1/PgP efflux pump bispecific antibody (Kenjockety Biotechnology)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionProgrammed death-ligand 1 blockersP-glycoprotein 1 inhibitors
TargetsProgrammed death-ligand 1P-glycoprotein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKenjockety Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesKenjockety Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A